CTSO

Cytosorbents Corp

• TipRanks·5d ago

  CytoSorbents Receives Nasdaq Extension to Regain Compliance

• Reuters·5d ago

  CytoSorbents wins Nasdaq extension to regain $1 minimum bid compliance

• Reuters·5d ago

  CYTOSORBENTS CORP - CONSIDERING OPTIONS INCLUDING REVERSE STOCK SPLIT TO REGAIN COMPLIANCE - SEC FILING

• TipRanks·03/27 00:08

  Cytosorbents’ Earnings Call Balances Progress and Risk

• Dow Jones·03/26 18:57

  Cytosorbents Is Maintained at Buy by D. Boral Capital

• Seeking Alpha·03/25 22:46

  Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth

• TipRanks·03/25 20:48

  CytoSorbents Narrows Losses Amid Strategic Shift and Growth

• Reuters·03/25 20:25

  CytoSorbents 2025 revenue rises, net loss narrows

• TipRanks·03/25 20:11

  CytoSorbents reports Q4 adjusted EPS (7c) vs. (3c) last year

• Seeking Alpha·03/25 20:11

  Cytosorbents Non-GAAP EPS of -$0.07, revenue of $9.22M beats by $0.01M

• Benzinga·03/25 20:11

  CytoSorbents Q4 Adj. EPS $(0.07) Misses $(0.05) Estimate, Sales $9.234M Miss $9.587M Estimate

• Reuters·03/25 20:09

  CytoSorbents FY2025 net loss narrows to $8 million; revenue rises 4% to $37.1 million

• Reuters·03/25 20:06

  CYTOSORBENTS REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

• Seeking Alpha·03/25 14:00

  Here are the major earnings after the close Wednesday

• Benzinga·03/25 11:11

  Earnings Scheduled For March 25, 2026